The Risk of End‐Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 10, 2015-10 ,pp. : 2732-2738

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1643-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival outcomes in liver transplant recipients with Model for End‐stage Liver Disease scores of 40 or higher: a decade‐long experience

By  

HPB, Vol. 17, Iss. 12, 2015-12 ,pp. : 1074-1084

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neural Network Analysis to Predict Mortality in End-Stage Renal Disease: Application to United States Renal Data System

By  

Nephron Clin Pract, Vol. 116, Iss. 2, 2010-06 ,pp. : c148-c158

Karger

Access to resources Recommend Favorite

Lifetime end‐stage kidney disease risk estimation in living kidney donor candidates remains a challenge

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 31, Iss. 1, 2018-01 ,pp. : 118-120

John Wiley & Sons Inc

Access to resources Recommend Favorite